Abstract
The care of the pregnant woman with cancer represents an immense challenge for doctors and other health professionals because of the complex ethical and therapeutic dilemmas raised. Appropriate and timely investigation and treatment may be lifesaving for the mother, but may have devastating effects on the developing fetus. Cancer occurs rarely in pregnancy, complicating approximately 1 in 1,000 live births. As women delay their first pregnancy to their third and fourth decades, the number of women suffering malignancy in pregnancy is expected to rise. Women with malignancy should be managed by a specialist multidisciplinary team including obstetricians, medical and surgical oncologists, radiologists, oncology nurses and midwives.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Antenatal care: Routine care for the healthy woman (2003). NICE Clinical Guideline CG 006
Pentheroudakis G, Pavlidis N (2006) Cancer and pregnancy: poena magna, not anymore. Eur J Cancer 42(2): 126–140
Periconceptional folic acid and food fortification in the prevention of neural tube defects (2003). RCOG Scientific advisory committee opinion paper 4
Leiserowitz GS (2006) Managing ovarian masses in pregnancy. Obstet Gynecol Surv 61(7): 463–470
Fattibene P, Mazzei F, Nuccetelli C, Risica S (1999) Prenatal exposure to ionising radiation: sources, effects and regulatory aspects. Acta Paediatr 88: 693–702
Koren G, Florescu A, Costei AM, Boskovic R, Moretti ME (2006) Nonsteroidal anti-inflammatory drugs during third trimester and the risk of premature closure of the ductus arteriosus: a meta-analysis. Ann Pharmacother 40(5): 824–829
Kenyon S, Boulvain M, Neilson J (2004) Antibiotics for preterm rupture of membranes: a systematic review. Obstet Gynecol 104(5 pt 1): 1051–1057
Nahum GG, Uhl K, Kennedy DL (2006) Antibiotic use in pregnancy and lactation: what is and is not known about teratogenic and toxic risks. Obstet Gynecol 107(5): 1120–1138
Mole RH (1987) Irradiation of the embryo and fetus. Br J Radiol 60: 17–31
Partridge AH, Garber JE (2000) Long-term outcomes of children exposed to anti-neoplastic agents in utero. Semin Oncol 27: 712–726
Wood NS, Marlow N, Costeloe K, Gibson AT, Wilkinson AR (2000) Neurologic and developmental disability after extremely preterm birth. EPICure Study Group. N Engl J Med 343: 378–384
Costeloe K (2006) EPICure: facts and figures: why preterm labour should be treated. BJOG 113 (Suppl 3): 10–12
Vanhaesebrouck P, Allegaert K, Bottu J, Debauche C, Devlieger H, Docx M et al. (2004) The EPIBEL study: outcomes to discharge from hospital for extremely pre-term infants in Belgium. Pediatrics 114: 663–675
Antenatal corticosteroids to prevent respiratory distress syndrome (2004) RCOG Green top guideline No. 7
Caesarean section (2004) National collaborating centre for women’s and children’s health. Clinical guideline
Reynosa E, Shepherd F, Messner H et al. (1987) Acute leukaemia in pregnancy: The Toronto Leukaemia Study Group experience with long-term follow-up of children exposed in utero to chemotherapeutic agents. J Clin Oncol 5: 1098–1106
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Dhanjal, M., Mitrou, S. (2008). The Obstetric Care of the Pregnant Woman with Cancer . In: Cancer and Pregnancy. Recent Results in Cancer Research, vol 178. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-71274-9_17
Download citation
DOI: https://doi.org/10.1007/978-3-540-71274-9_17
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-71272-5
Online ISBN: 978-3-540-71274-9
eBook Packages: MedicineMedicine (R0)